Literature DB >> 9153246

Agonist-induced desensitization, internalization, and phosphorylation of the sst2A somatostatin receptor.

R W Hipkin1, J Friedman, R B Clark, C M Eppler, A Schonbrunn.   

Abstract

Cellular responsiveness to the inhibitory peptide somatostatin (SRIF) or its clinically used analogs can desensitize with agonist exposure. While desensitization of other seven-transmembrane domain receptors is mediated by receptor phosphorylation and/or internalization, the mechanisms mediating SRIF receptor (sst) desensitization are unknown. Therefore, we investigated the susceptibility of the sst2A receptor isotype to ligand-induced desensitization, internalization, and phosphorylation in GH-R2 cells, a clone of pituitary tumor cells overexpressing this receptor. A 30-min exposure of cells to either SRIF or the analog SMS 201-995 (SMS) reduced both the potency and efficacy of agonist inhibition of adenylyl cyclase. Internalization of receptor-bound ligand was rapid (t1/2 = 4 min) and temperature-dependent. SRIF and SMS increased the phosphorylation of the 71-kDa sst2A protein 25-fold within 15 min. Receptor phosphorylation was dependent on both the concentration and time of agonist exposure and was not affected by pertussis toxin pretreatment, indicating that receptor occupancy rather than second messenger formation was required. Receptor phosphorylation was also stimulated by phorbol 12-myristate 13-acetate activation of protein kinase C. Both ligand-stimulated and phorbol 12-myristate 13-acetate-stimulated receptor phosphorylation occurred primarily on serine. These studies are the first demonstration of agonist-dependent desensitization, internalization, and phosphorylation of the sst2A receptor and suggest that phosphorylation may mediate the homologous and heterologous regulation of this receptor.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9153246     DOI: 10.1074/jbc.272.21.13869

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Ligand internalization and recycling by human recombinant somatostatin type 4 (h sst(4)) receptors expressed in CHO-K1 cells.

Authors:  K S Smalley; J A Koenig; W Feniuk; P P Humphrey
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

2.  Somatostatin-induced regulation of SST(2A) receptor expression and cellsurface availability in central neurons: role of receptor internalization.

Authors:  H Boudin; P Sarret; J Mazella; A Schonbrunn; A Beaudet
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

3.  Phosphorylation of sst2 receptors in neuroendocrine tumors after octreotide treatment of patients.

Authors:  Beatrice Waser; Renzo Cescato; Qisheng Liu; Yachu J Kao; Meike Körner; Emanuel Christ; Agnes Schonbrunn; Jean Claude Reubi
Journal:  Am J Pathol       Date:  2012-05       Impact factor: 4.307

4.  Ligand-dependent mechanisms of sst2A receptor trafficking: role of site-specific phosphorylation and receptor activation in the actions of biased somatostatin agonists.

Authors:  Yachu J Kao; Madhumita Ghosh; Agnes Schonbrunn
Journal:  Mol Endocrinol       Date:  2011-04-14

Review 5.  Selective agonism in somatostatin receptor signaling and regulation.

Authors:  Agnes Schonbrunn
Journal:  Mol Cell Endocrinol       Date:  2007-10-07       Impact factor: 4.102

6.  Differential temporal and spatial regulation of somatostatin receptor phosphorylation and dephosphorylation.

Authors:  Madhumita Ghosh; Agnes Schonbrunn
Journal:  J Biol Chem       Date:  2011-02-22       Impact factor: 5.157

7.  Interrelationships between somatostatin sst2A receptors and somatostatin-containing axons in rat brain: evidence for regulation of cell surface receptors by endogenous somatostatin.

Authors:  P Dournaud; H Boudin; A Schonbrunn; G S Tannenbaum; A Beaudet
Journal:  J Neurosci       Date:  1998-02-01       Impact factor: 6.167

8.  Pharmacological characterization of human S1P4 using a novel radioligand, [4,5-3H]-dihydrosphingosine-1-phosphate.

Authors:  James Fossetta; Gregory Deno; Waldemar Gonsiorek; Xuedong Fan; Brian Lavey; Pradip Das; Charles Lunn; Paul J Zavodny; Daniel Lundell; R William Hipkin
Journal:  Br J Pharmacol       Date:  2004-06-14       Impact factor: 8.739

9.  Somatostatin type-2 receptor activation inhibits glutamate release and prevents status epilepticus.

Authors:  Maxim Kozhemyakin; Karthik Rajasekaran; Marko S Todorovic; Samuel L Kowalski; Corinne Balint; Jaideep Kapur
Journal:  Neurobiol Dis       Date:  2013-03-05       Impact factor: 5.996

10.  Site specificity of agonist and second messenger-activated kinases for somatostatin receptor subtype 2A (Sst2A) phosphorylation.

Authors:  Qisheng Liu; Mark S Bee; Agnes Schonbrunn
Journal:  Mol Pharmacol       Date:  2009-04-23       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.